Bjortin-M
Description_Effects
Bjortin-M is a combination medication containing Bilastine and Montelukast, designed to provide comprehensive relief from allergic conditions and respiratory symptoms. This dual-action formula effectively manages seasonal and perennial allergic rhinitis, as well as asthma-related symptoms caused by inflammation and allergic triggers. Bilastine is a modern, non-sedating antihistamine that works by blocking histamine H1 receptors, which are responsible for symptoms such as sneezing, itching, watery eyes, runny nose, and skin rashes. Its fast onset and 24-hour duration make it ideal for once-daily use without causing daytime drowsiness or impairing cognitive function. Montelukast is a leukotriene receptor antagonist that helps by blocking leukotrienes—chemical messengers involved in airway inflammation, bronchoconstriction, and mucus production. This action provides added benefit in allergic rhinitis, especially in patients with co-existing mild asthma or nighttime symptoms like coughing, wheezing, or chest tightness. Together, Bilastine and Montelukast work synergistically to not only control upper respiratory allergy symptoms, but also improve airway function, offering broader protection than antihistamines alone. Bjortin-M is typically taken once daily in the evening and is well tolerated in most individuals, with rare side effects like headache, stomach upset, or fatigue. Bjortin-M ensures long-lasting comfort and improves quality of life in patients with allergic rhinitis, chronic urticaria, or asthma-related symptoms.
